Hair Repigmentation Outcomes in Patients With Graying Hair Treated With Exosome Therapy: A Cross‐Sectional Observational Study
Journal of Cosmetic Dermatology · 2025-11 · 24 (11)
DOI: 10.1111/jocd.70526 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 07.11.2025. Verfasst von Suparuj Lueangarun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aesthetic Medicine, College of Integrative Medicine, Dhurakij Pundit University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Hair Color, Exosomes, Alopecia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hair graying is an age‐associated condition primarily caused by the depletion and dysfunction of melanocyte stem cells within hair follicles. Emerging regenerative strategies, including exosome‐based therapies, offer the potential to restore pigmentation by targeting underlying cellular mechanisms.
Objective
To investigate the clinical outcomes and correlates of hair repigmentation following exosome‐based therapy in individuals with gray hair.
Methods
This cross‐sectional observational study enrolled 10 patients with visible gray or white hair who were treated with rose stem cell‐derived exosomes (RSCEs) using various procedures. Gray hair repigmentation outcomes were assessed using a standardized scale. Statistical correlations between clinical variables and treatment responses were analyzed.
Results
A mean of 4.6 ± 1.3 treatment sessions was performed. Repigmentation was observed after an average of 2.4 ± 0.7 sessions and was maintained for 4.7 ± 1.9 months. The various treatment modalities also demonstrated efficacy in both hair regrowth and hair repigmentation. The mean outcome score was 2.8 ± 0.78, with 60% achieving a higher‐grade response (≥ 50% improvement). Shorter duration of graying ( p = 0.0363), presence of androgenetic alopecia (AGA) ( p = 0.0332), and moderate baseline severity (Stage 2) ( p = 0.0133) were significantly associated with better outcomes. No adverse events were reported.
Conclusion
Exosome‐based therapy appears to be a safe and promising approach for inducing hair repigmentation in individuals with gray hair using various treatment modalities. Factors such as the presence of AGA, shorter duration of graying, and moderate baseline severity may predict a better response. Larger, controlled studies are warranted to validate these findings and help standardize treatment protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Aesthetic Medicine, College of Integrative Medicine, Dhurakij Pundit University, Bangkok, Thailand.
- Division of Dermatology, DeMed Clinic Center, Bangkok, Thailand.
- Huang PH Dermatology and Aesthetics, Kaohsiung, Taiwan (ROC).
- Sincere Dermatology Clinic, Taipei City, Taiwan (ROC).
- Pretty You Dermatology Clinic, Athens, Greece.
- DL Dermatology and Laser Clinic, Rio de Janeiro, Brazil.
ORCID-Profile: Suparuj Lueangarun, Patrick Po-Han Huang, Wan-Yi Chou
Zitieren
APA
Lueangarun, S., Huang, P. P., Chou, W. Y., Theodorakopoulou, E., & Lemes, D. (2025). Hair Repigmentation Outcomes in Patients With Graying Hair Treated With Exosome Therapy: A Cross‐Sectional Observational Study. Journal of Cosmetic Dermatology, 24(11). https://doi.org/10.1111/jocd.70526
Vancouver
Lueangarun S, Huang PP, Chou WY, Theodorakopoulou E, Lemes D. Hair Repigmentation Outcomes in Patients With Graying Hair Treated With Exosome Therapy: A Cross‐Sectional Observational Study. Journal of Cosmetic Dermatology. 2025;24(11). doi:10.1111/jocd.70526
BibTeX
@article{Lueangarun2025,
author = {Lueangarun, Suparuj and Huang, Patrick Po-Han and Chou, Wan-Yi and Theodorakopoulou, Elina and Lemes, Daniela},
title = {Hair Repigmentation Outcomes in Patients With Graying Hair Treated With Exosome Therapy: A Cross‐Sectional Observational Study},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {11},
doi = {10.1111/jocd.70526}
}
EUVIMED